Breaking News Instant updates and real-time market news.

LGND

Ligand

$226.66

1.66 (0.74%)

16:03
08/06/18
08/06
16:03
08/06/18
16:03

Ligand raises FY18 EPS to $6.30 from $6.15, consensus $6.21

Raises FY18 revenue to $232M from $226M, consensus $216.58M

  • 06

    Aug

  • 06

    Nov

LGND Ligand
$226.66

1.66 (0.74%)

07/18/18
HCWC
07/18/18
NO CHANGE
Target $245
HCWC
Buy
Ligand target raised to $245 on better Promacta sales at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals (LGND) to $245 from $239 after its partner Novartis (NVS) this morning announced Q2 Promacta revenue of $292M, above his estimate of $258M. The analyst expects Promacta to achieve blockbuster status in 2018. He keeps a Buy rating on Ligand.
06/28/18
HCWC
06/28/18
NO CHANGE
Target $239
HCWC
Buy
Ligand price target raised to $239 from $182 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals to $239 after the company amended its OmniAb agreement with WuXi Biologics and received a $47M payment. With its "coffers overflowing" with cash, the analyst expects Ligand's "strategic shopping should ramp up even more." Further, the company could also be highly selective in bringing additional internal pipeline assets forward, such as CE-Iohexol, expected to enter the clinic late 2018, Pantginis tells investors in a research note. He maintains a Buy rating on Ligand.
06/27/18
CHLM
06/27/18
NO CHANGE
Target $230
CHLM
Buy
Ligand price target raised to $230 from $200 at Craig-Hallum
Craig-Hallum analyst Matt Hewitt raised his price target for Ligand to $230 from $200 following the company's announcement that WuXi Biologics has amended its license agreement for the OmniAb platform and has made a cash payment of $47M to Ligand. The analyst continues to believe that Ligand is a unique asset geared to provide investors with excellent earnings growth over the next several years as it layers in additional commercial assets from its extensive partnered pipeline. He reiterates a Buy rating on the shares.
06/21/18
ARGS
06/21/18
INITIATION
Target $260
ARGS
Buy
Ligand initiated with a Buy at Argus
Argus analyst Mike Jaffe initiated Ligand Pharmaceuticals with a Buy rating and a price target of $260, saying the company is on track to generate solid earnings growth over the next several years thanks to its primary products - Promacta with use in blood clotting and Kyprolis for treatment of multiple myeloma. Jaffe adds that the company also has a "strong pipeline", with over half of its 165 programs under license currently in the clinical development or later stage. The analyst is also positive on Ligand's valuation at a PEG ratio of 1.2-times, which is "well below" the peer biotech industry average of 1.8-times.

TODAY'S FREE FLY STORIES

PDLB

PDL Community Bancorp

$13.63

-0.01 (-0.07%)

14:21
03/22/19
03/22
14:21
03/22/19
14:21
Hot Stocks
PDL Community Bancorp to repurchase up to 923,151 common shares »

PDL Community Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
03/22/19
03/22
14:17
03/22/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNI

Scripps Networks

$0.00

(0.00%)

, LXRX

Lexicon

$7.51

-0.45 (-5.65%)

14:16
03/22/19
03/22
14:16
03/22/19
14:16
Hot Stocks
Sanofi says FDA issues CRL for Zynquista »

The U.S. Food and Drug…

SNI

Scripps Networks

$0.00

(0.00%)

LXRX

Lexicon

$7.51

-0.45 (-5.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 25

    Apr

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
03/22/19
03/22
14:16
03/22/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMN

AMN Healthcare

$48.35

-0.895 (-1.82%)

14:15
03/22/19
03/22
14:15
03/22/19
14:15
Conference/Events
AMN Healthcare management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 17

    Apr

W

Wayfair

$159.46

-11.73 (-6.85%)

14:15
03/22/19
03/22
14:15
03/22/19
14:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
03/22/19
03/22
14:15
03/22/19
14:15
General news
U.S. Treasury reported a -$234 B budget deficit for February »

U.S. Treasury reported a…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

14:13
03/22/19
03/22
14:13
03/22/19
14:13
Periodicals
Trump to withdraw new North Korea-related sanctions, CNBC says »

U.S. President Donald…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-4.92 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$123.24

-2.89 (-2.29%)

14:11
03/22/19
03/22
14:11
03/22/19
14:11
Conference/Events
Amedisys management to meet with Wiliam Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 03

    Apr

NEM

Newmont Mining

$34.57

0.25 (0.73%)

, GG

Goldcorp

$10.71

-0.46 (-4.12%)

14:10
03/22/19
03/22
14:10
03/22/19
14:10
Periodicals
VanEck wants Newmont to renegotiate terms of Goldcorp deal, WSJ reports »

Joe Foster, who runs one…

NEM

Newmont Mining

$34.57

0.25 (0.73%)

GG

Goldcorp

$10.71

-0.46 (-4.12%)

GOLD

Barrick Gold

$13.48

0.2 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

14:10
03/22/19
03/22
14:10
03/22/19
14:10
General news
U.S. Treasury budget preview: »

U.S. Treasury budget…

AGO

Assured Guaranty

$45.19

-0.14 (-0.31%)

14:07
03/22/19
03/22
14:07
03/22/19
14:07
Conference/Events
Assured Guaranty management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 29

    Mar

  • 16

    Apr

  • 17

    Apr

14:03
03/22/19
03/22
14:03
03/22/19
14:03
General news
Treasury Budget data reported »

February Treasury Budget…

QCOM

Qualcomm

$57.16

-0.6 (-1.04%)

14:00
03/22/19
03/22
14:00
03/22/19
14:00
Options
Size spread in Qualcomm as shares slip »

Size spread in Qualcomm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EVER

EverQuote

$7.80

-0.1 (-1.27%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
EverQuote management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

RYTM

Rhythm Pharmaceuticals

$30.01

-0.64 (-2.09%)

13:59
03/22/19
03/22
13:59
03/22/19
13:59
Conference/Events
Rhythm Pharmaceuticals management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TWOU

2U

$66.19

-2.92 (-4.23%)

13:57
03/22/19
03/22
13:57
03/22/19
13:57
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

GLW

Corning

$33.89

-0.91 (-2.61%)

13:55
03/22/19
03/22
13:55
03/22/19
13:55
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATEC

Alphatec

$2.60

-0.12 (-4.41%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Alphatec management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

TLRA

Telaria

$6.16

-0.25 (-3.90%)

13:52
03/22/19
03/22
13:52
03/22/19
13:52
Conference/Events
Telaria management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

SRDX

Surmodics

$42.26

-3.67 (-7.99%)

13:51
03/22/19
03/22
13:51
03/22/19
13:51
Conference/Events
Surmodics management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

TPR

Tapestry

$31.23

-0.72 (-2.25%)

13:49
03/22/19
03/22
13:49
03/22/19
13:49
Options
Tapestry option volume 4x normal as shares test multiyear lows »

Tapestry option volume 4x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

, RHHBY

Roche

$0.00

(0.00%)

13:46
03/22/19
03/22
13:46
03/22/19
13:46
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary at Piper Jaffray »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$78.80

-1.73 (-2.15%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

13:45
03/22/19
03/22
13:45
03/22/19
13:45
General news
Treasury Budget to be reported at 14:00 »

February Treasury Budget…

SLCA

U.S. Silica

$15.90

-1.08 (-6.36%)

13:40
03/22/19
03/22
13:40
03/22/19
13:40
Options
6.3% drop in Silica motivates an upside call buyer »

6.3% drop in Silica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.